¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"È£"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
GnRH agonist
»ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
gonadotrophin
»ý½Ä»ùÀÚ±ØÈ£¸£¸ó, ¼º¼±ÀÚ±ØÈ£¸£¸ó
gonadotropic hormone
»ý½Ä»ùÀÚ±ØÈ£¸£¸ó, »ý½Ä¼±ÀÚ±ØÈ£¸£¸ó
gonadotropic quotient
»ý½Ä»ùÀÚ±ØÈ£¸£¸óºñ
gonadotropin
»ý½Ä»ùÀÚ±ØÈ£¸£¸ó, ¼º¼±ÀÚ±ØÈ£¸£¸ó
gonadotropin-releasing hormone
»ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó, »ý½Ä¼±ÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó
gonadotropin-releasing hormone agonist
»ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
growth hormone
¼ºÀåÈ£¸£¸ó
growth hormone-inhibiting hormone
¼ºÀåÈ£¸£¸ó¾ïÁ¦È£¸£¸ó
growth hormone-releasing hormone
¼ºÀåÈ£¸£¸ó¹æÃâÈ£¸£¸ó
hypereosinophilia
°ú´ÙÈ£»ê±¸Áõ°¡Áõ
hypereosinophilic syndrome
°ú´ÙÈ£»ê±¸ÁõÈıº
hyperestrinism
¿©¼ºÈ£¸£¸ó°ú´Ù(Áõ), °í¿¡½ºÆ®¸°Áõ
hypergonadotropic eunuchoidism
»ý½Ä»ùÀÚ±ØÈ£¸£¸ó°ú´ÙÀ¯»ç°íÀÚÁõ
hypergonadotropic hypogonadism
°í»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
breathing system
È£ÈíÀåÄ¡
hypoventilation
È£ÈíÀúÇÏ, ȯ±âÀúÇÏ
hypoventilation syndrome
È£ÈíÀúÇÏÁõÈıº
respiratory resistance
È£ÈíÀúÇ×
respiratory mucosa
È£ÈíÁ¡¸·
respiratory arrest
È£ÈíÁ¤Áö
respiratory standstill
È£ÈíÁ¤Áö
respiration regulation
È£ÈíÁ¶Àý
pneumotaxic center
È£ÈíÁ¶Á¤ÁßÃß
breathing bag reservoir
È£ÈíÁÖ¸Ó´Ï
respiratory bag
È£ÈíÁÖ¸Ó´Ï
breath holding attack
È£ÈíÁßÁö¹ßÀÛ
breath holding spell
È£ÈíÁßÁö¹ßÀÛ, ¼ûÂü±â¹ßÀÛ
breath holding test
È£ÈíÁßÁö½ÃÇè, È£ÈíÁßÁö°Ë»ç
respiratory center
È£ÈíÁßÃß
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
district nurse
(¢¡community) Áö¿ª»çȸ°£È£»ç
drug interaction
¾à¹°»óÈ£ÀÛ¿ë
ear protection device
¹æÀ½º¸È£±¸, ±Í¸¶°³
exertional dyspnea
¿îµ¿È£Èí°ï¶õ
expiratory dyspnea
³»½¬±â°ï¶õ, È£½ÄÈ£Èí°ï¶õ
hormonal disorder
³»ºÐºñÀå¾Ö, È£¸£¸óÀå¾Ö
idiopathic respiratory distress
Ư¹ßÈ£Èí°ï¶õ
inspiratory dyspnea
µé¿©½¬±â°ï¶õ, Èí½ÄÈ£Èí°ï¶õ
mucosal protective drug
Á¡¸·º¸È£Á¦
nocturnal dyspnea
¾ß°£È£Èí°ï¶õ
orthostatic dyspnea
¼¼½¬±âÈ£Èí°ï¶õ, ±â¸³È£Èí°ï¶õ
paroxysmal dyspnea
¹ßÀÛÈ£Èí°ï¶õ
paroxysmal nocturnal dyspnea
¹ßÀ۾߰£È£Èí°ï¶õ
phase encode direction
À§»óºÎȣȹæÇâ
quadrature signal detection
±¸Àû½ÅȣŽÁö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
antihormone
¾ÈƼȣ¸£¸ó, Ç×È£¸£¸ó.
antimullerian hormone
Ç× ¹Ä·¯¸®¾È È£¸£¸ó
antimullerian hormone
Ç×¹Á·¯¸®¾È È£¸£¸ó
antineutrophil cytoplasmic autoantibody
Ç×È£Áß±¸ ¼¼Æ÷Áú ÀÚ°¡Ç×ü
antiprolactin antibody
Ç×ÇÁ·Î¶ôƾ Ç×ü,Ç×À¯ÁóºÐºñÈ£¸£¸óÇ×ü
ards(adult respiratory disress syndrome)
ARDS(¼ºÀÎÈ£Èí°ï¶õÁõÈıº)(à÷ìÑû¼ýåÍÝÑññøý¦ÏØ)
argininosuccinic aciduria
¾Æ¸£±â´Ñ È£¹Ú»ê´¢.
arginosuccinic lyase
¾Æ¸£±â´ÑÈ£¹Ú»ê¸®¾ÆÁ¦<--Àý´ÜÈ¿¼Ò>
arsenic paste
¾Æºñ»êÈ£Á¦(ä¬Ý÷ß«ûÕð¥).
arsenicophagy
ºñ¼Ò±âÈ£Áõ(¡Ðîû¿ñø).
artificial breathing =a. respiration
ÀΰøÈ£Èí(¡û¼ýå).
artificial respiration
ÀΰøÈ£Èí(ìÑÍïû¼ýå)
artificial respiration
ÀΰøÈ£Èí.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
acidophilic metamyelocyte juvenile acidophilic leukocyte
È£»ê¼º´Ê°ñ¼ö¼¼Æ÷ ¾î¸°È£»ê¼º¹é
acidophilic leukocyte
È£»ê¼º¹éÇ÷±¸
eosinophilic leukocyte
È£»ê¼º¹éÇ÷±¸
acidophilic adenoma
È£»ê¼º¼±Á¾
acidophilic cell
È£»ê¼º¼¼Æ÷
oxyphilic cell
È£»ê¼º¼¼Æ÷
oxyphil
È£»ê¼ºÀÇ, »êģȼºÀÇ.
acidophilic erythroblast
È£»ê¼ºÀûÇ÷±¸¸ð¼¼Æ÷
acidophilic body
È£»ê¼ºÃ¼(û¿ß«àõô÷)
acidophilic promyelocyte
È£»ê¼ºÇ²°ñ¼ö¼¼Æ÷
acidophile
È£»ê¼¼±Õ
bacterium, acidophilic(-phil)
È£»ê¼¼±Õ
oxyphilic adenoma
È£»ê¼¼Æ÷¼±Á¾(û¿ß«á¬øààÍðþ)
arcwise connection
È£»ó¿¬°á(¡È£»ó¿¬°á).
pes arcuatus ³ª
È£»óÁ·(ûÁßÒðë)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
basophilic hyperpituitarism
È£¿°±â¼º ³úÇϼöü±â´ÉÇ×ÁøÁõ.
basophilic hypersensitivity
È£¿°±â±¸ °ú¹Î¹ÝÀÀ
basophilic leukemia
È£¿°±â¼º ¹éÇ÷º´(?ËÑÌ´ËÓ).
basophilic leukemia
È£¿°±â±¸¼º ¹éÇ÷º´(¡ÛÜúìÜ»).
basophilic leukocyte
È£¿°±â±¸<¼¼Æ÷>(Ì´Ëç˻˴ËṴ̂).
basophilic leukocyte
È£¿°±â¼º¹éÇ÷±¸
basophilic metaleukocyte juvenile basophilic leukocyte
È£¿°±â¼º´Ê°ñ¼ö¼¼Æ÷ ¾î¸°È£¿°±â
basophilic myelocyte
È£¿°±â¼º °ñ¼ö±¸(?ËËàË´).
basophilic myelocyte
È£¿°±â¼º°ñ¼ö¼¼Æ÷
basophilic normoblast
È£¿°±â¼º Á¤Àû¾Æ±¸(?ËøËøËâË´).
basophilic promyelocyte
È£¿°±â¼ºÇ²°ñ¼ö¼¼Æ÷
basophilic stippling
È£¿°±â¼º ¹ÝÁ¡
basophils
È£¿°±â±¸<¼¼Æ÷>.
bell note
¹æ¿ï¼Ò¸® È£ÈíÀ½.
big brg prolactin
°Å´ë À¯ÁóºÐºñÈ£¸£¸ó
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
shield
"º¸È£ÆÇ(ÜÁûÞ÷ù), Â÷´ÜÆÇ(ó´Ó¨÷ù)"
short range interaction
´Ü¹üÀ§ »óÈ£ÀÛ¿ë(ÓÛôêÌßÓû»íÂéÄ)
signal amplification
½ÅÈ£ÁõÆø(ãáûÜñòøë)
signal codons
½ÅÈ£(ãáûÜ)ÄÚµ·
signal hypothesis
½ÅÈ£¼³(ãáûÜàã)
signal peptide
½ÅÈ£(ãáûÜ)ÆéŸÀ̵å
signal peptidase
½ÅÈ£(ãáûÜ)ÆéƼµ¥À̽º
signal recognition protein
½ÅÈ£ÀÎÁö´Ü¹éÁú(ãáûÜìãò±Ó±ÛÜòõ)
signal sequence
½ÅÈ£¼¿(ãáûÜßíÖª)
signal-to-noise ratio
½ÅÈ£/ÀâÀ½ºñ(ãáûÜ/íÚëåÝï)
sign inversion mechanism
½ÅÈ£¹ÝÀü±âÀü(ãáûÜÚãï®Ñ¦ï®)
sign mutation
½ÅÈ£º¯ÀÌ(ãáûÜܨì¶)
somatotropin regulatory hormone
¼Ò¸¶Å䯮·ÎÇÉ Á¶Àý(ðàï½)È£¸£¸ó
somatotropin releasing hormone
¼Ò¸¶Å䯮·ÎÇÉ ¹æÃâ(Û¯õó) È£¸£¸ó
specific interaction theory
ƯÀÌ »óÈ£ÀÛ¿ëÀÌ·Ð(÷åì¶ßÓû»íÂéÄ×âÖå)
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
12
ÄÚµå
¿µ¹®
ÇѱÛ
J68
Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
ÈÇй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±èÀÇ ÈíÀÔ¿¡ ÀÇÇÑ È£Èí±â º´ÅÂ
J68.3
Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
ÈÇй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ ±âŸ ±Þ¼º ¹× ¾Æ±Þ¼º È£Èí±â º´ÅÂ
J68.4
Chronic respiratory conditions due to chemicals, gases, fumes and vapours
ÈÇй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ ¸¸¼º È£Èí±â º´ÅÂ
J68.8
Other respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
±âŸ ÈÇй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ È£Èí±â º´ÅÂ
J68.9
Unspecified respiratory condition due to inhalation of chemicals, gases, fumes and vapours
»ó¼¼ºÒ¸íÀÇ ÈÇй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ È£Èí±â º´ÅÂ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
¼³¸í
expiration
È£±â, È£½Ä, ³»½°
¼ûÀ» ³»½¬´Â µ¿ÀÛ. Æó·ÎºÎÅÍ °ø±â¸¦ ¹èÃâÇÏ´Â °Í.
expiratory
È£±âÀÇ
expiratory dyspnea
È£½Ä¼º È£Èí °ï¶õ
expiratory phase
È£±â
expiratory reserve volume
È£½Ä¼º ¿¹ºñ ¿ëÀû, È£±â ¿¹ºñ·®, ¿¹ºñ È£±â·®
¾ÈÁ¤ »óÅÂÀÇ È£½Ä ÈÄ ÃÖ´ë·Î È£ÃâÇÒ ¼ö ÀÖ´Â °ø±â·®À¸·Î¼, ¾à 1200mlÀÌ´Ù.
expiratory vital capacity
È£½Ä ÆóȰ·®
expired
È£±âÀÇ
expired air breathing
È£±â È£Èí¹ý
expired gas
È£±â
expressive or signal output process
Ç¥Çö¼º, ȤÀº ½ÅÈ£ÀÇ Ãâ·ÂÈ °úÁ¤
external respiration
¿ÜÈ£Èí
ÆóÀå°ú ´ë±â »çÀÌ¿¡¼ ÀϾ´Â °¡½º ±³È¯.
facial protector
¾È¸é º¸È£±â, ¾È¸é ½Å°æ º¸È£±â
familial neutropenia
°¡Á·¼º È£Áß±¸ °¨¼ÒÁõ
favoring
¼±È£ÇÏ´Â
female hormone
¿©¼º È£¸£¸ó
ôÃß µ¿¹° ¾ÏÄÆÀÇ ³¼Ò¿¡¼ ºÐºñµÇ¾î ¼º±âÀÇ ¹ßÀ°°ú »ý½Ä±â´É Á¶Àý µî¿¡ ÀÛ¿ëÇÏ´Â ¼º È£¸£¸ó. ³¼Ò È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. ¿©Æ÷¿¡¼ ³ª¿À´Â ¿©Æ÷ È£¸£¸ó°ú Ȳü¿¡¼ ³ª¿À´Â Ȳü È£¸£¸óÀÌ ÀÖ´Ù. ÀÇ¾à ¹æ¸é¿¡¼ º¸Åë ¿©¼º È£¸£¸óÀ̶ó°í ÇÒ ¶§´Â ¿©Æ÷ È£¸£¸óÀ» ¸»ÇÑ´Ù. ¿©Æ÷ È£¸£¸óÀº ¹ßÁ¤ È£¸£¸óÀ¸·Î ¿©¼º »ý½Ä±âÀÇ ¹ßÀ°À» ÃËÁøÇÏ¿© ¿©¼º´Ù¿òÀ» ÁõÁø½ÃŲ´Ù. Ȳü È£¸£¸óÀº ¹ßÁ¤ È£¸£¸ó¿¡ ±æÇ×ÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¹ßÁ¤À» ¾ïÁ¦ÇÑ´Ù. À̵é È£¸£¸óÁ¦ÀÇ »ç¿ëÀº ÀÎü¿¡ ÀÌ»óÇÑ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ¼ö°¡ ÀÖÀ¸¹Ç·Î ±× »ç¿ëÀº ¹Ýµå½Ã Àü¹® ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó¾ß ÇÑ´Ù. ¹ßÁ¤ È£¸£¸óÀÇ ÀÛ¿ëÀ» °¡Áø ¹°ÁúÀ» ÃÑÄªÇØ¼ ¿¡½ºÆ®·Î°Õ
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
magniloquent
È£¾ðÀå´ãÇÏ´Â
magniloquent
È£¾ðÀå´ãÇÏ´Â;°úÀåÇÑ
rant
È£¾ðÇÏ´Ù
Hohenstaufed
È£¿£½´Å¸¿ìÆæ(12-13¼¼±âÀÇ µ¶ÀÏÀÇ ¿Õ°¡)
Hohenzollern
È£¿£ÃÍ·¹¸¥°¡(ÀÇ »ç¶÷)(1871-1918³â µ¶ÀÏÀ» Áö¹èÇÑ ¿Õ°¡)
mouthfilling
È£¿¬ Àå´ãÇÏ´Â
halophile
È£¿°±Õ
basophil
È£¿°±â¼º
basophile
È£¿°±â¼º
basophil
È£¿°±â¼º ¹éÇ÷±¸
basophile
È£¿°±â¼º ¼¼Æ÷(ƯÈ÷ ¹éÇ÷±¸)
basophilic
È£¿°±â¼º ¼¼Æ÷(ƯÈ÷ ¹éÇ÷±¸)ÀÇ
halobacteria
È£¿°¼º ¼¼±Õ
drencher
È£¿ì;Æø¿ì;(¸¶¼Ò¿ëÀÇ)¹°¾à ¸ÔÀÌ´Â ±â±¸
bodyguard
È£À§;È£À§º´
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
quixotism
µ¿Å°È£Å×ÀûÀÎ ¼º°Ý
quixotry
µ¿Å°È£Å×ÀûÀÎ ¼º°Ý
rant
È£¾ðÇÏ´Ù
reciprocal
¼·Î°£ÀÇ; »óÈ£ÀÇ
reciprocity
»óÈ£°ü°è
refuge
º¸È£(ÀÚ); À§¾È¹°; Çdz(ó)
resolute
´ÜÈ£ÇÑ; ±»°ÇÇÑ
respiration
È£Èí
respirator
ÀΰøÈ£Èí
respiratory
È£ÈíÀÇ
respire
È£ÈíÇÏ´Ù
rifle pit
»ç°ÝÈ£
rye
È£¹Ð
safeguard
À» º¸È£ÇÏ´Ù
salacious
È£»öÀûÀÎ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½